Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,865.00    0.00 (0.00%)
Bid:
2,855.00
Ask:
2,860.00
Spread: 5.00 (0.175%)
Market Cap: £2.24b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

19 Mar 2026 13:30

RNS Number : 3657X
Hill & Smith PLC
19 March 2026
 

19 March 2026

Hill & Smith PLC ('Hill & Smith' or the 'Company')Director and PDMR Shareholdings

Hill & Smith announces the following dealings by Directors and PDMRs of the Company in connection with its employee share plan arrangements.

Hill & Smith 2023 Long Term Incentive Plan - 2026 Award ('LTIP')

On 18 March 2026 (the 'Grant Date'), the Company granted awards under the Hill & Smith 2023 Long Term Incentive Plan to the Directors / PDMRs as set out below:

Director / PDMR

Name

Job Title

Type of award

Number of shares

Director

Rutger Helbing

Chief Executive Officer

Nil-cost option

57,935

Director

Chris McLeish

Chief Financial Officer

Nil-cost option

32,717

PDMR

Tim Tehan

Group President

Conditional award

20,053

PDMR

Nick Adcock

Group President

Nil-cost option

13,482

 

The number of shares over which the awards were granted was calculated based on a share price of £21.25, that being the closing mid-market price from the day immediately preceding the date of grant.

The Awards will vest based on the achievement of relative Total Shareholder Return (40%), Underlying EPS Growth (50%) and the Company's reduction in greenhouse gas emissions (10%) over a 3-year performance period. The detailed performance conditions will be provided in the 2026 Directors' Remuneration Report.

The Awards will (subject to the achievement of the performance conditions) vest following the end of the performance period, for Rutger Helbing and Chris McLeish the LTIP may not ordinarily be exercised until the end of a further two-year holding period.

Deferred Bonus Plan awards in respect of 2025 bonuses

On 18 March 2026 the Company granted awards under the rules of its Deferred Bonus Plan in respect of bonuses earned for the year ended 31 December 2025. The Company confirms that:

Director / PDMR

Name

Job Title

Type of award

Number of shares

Director

Rutger Helbing

Chief Executive Officer

Nil-cost option

19,365

Director

Chris McLeish

Chief Executive Officer

Nil-cost option

2,378

PDMR

Tim Tehan

Group President

Conditional award

3,335

PDMR

Nick Adcock

Group President

Nil-cost option

1,596

 

The awards will vest following the end of a two-year deferral period.

The Notification of Dealing Forms for the above transactions are set out below:

Notification of Dealing Form for Rutger Helbing

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Rutger Helbing

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

57,935

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost option under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

19,365

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Notification of Dealing Form for Chris McLeish

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

32,717

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

2,378

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Notification of Dealing Form for Tim Tehan

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Tim Tehan

2.

Reason for the notification

(a)

Position/status

Group President

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of a Conditional Award under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

20,053

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of a Conditional Award under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

3,335

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

 

Notification of Dealing Form for Nicholas Adcock

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Nick Adcock

2.

Reason for the notification

(a)

Position/status

Group President

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith 2023 Long Term Incentive Plan

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

13,482

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Grant of nil-cost options under the Hill & Smith Deferred Bonus Plan

 

(d)

Price(s) and volume(s)

Price(s)

Volume

Nil

1,596

(e)

Aggregated information:

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

18 March 2026

(g)

Place of the transaction

Outside a trading venue

 

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKCBDNBKDBND
Date   Source Headline
27th Nov 200810:01 amRNSDirectors Additional Appointment
19th Nov 20083:17 pmRNSDirector/PDMR Shareholding
19th Nov 20087:00 amRNSInterim Management Statement
18th Nov 20083:57 pmRNSDisposal
27th Oct 20084:50 pmRNSSecond Price Monitoring Extn
27th Oct 20084:44 pmRNSPrice Monitoring Extension
27th Oct 20081:59 pmRNSDirector/PDMR Shareholding
21st Oct 20083:00 pmRNSDirector/PDMR Shareholding
17th Oct 20083:06 pmRNSDirector/PDMR Shareholding
13th Oct 200812:59 pmRNSDirector/PDMR Shareholding
8th Oct 20083:45 pmRNSDirector/PDMR Shareholding
6th Oct 200811:48 amRNSHolding(s) in Company
1st Oct 20084:10 pmRNSDirector/PDMR Shareholding
30th Sep 200810:06 amRNSTotal Voting Rights
24th Sep 20081:46 pmRNSDirector/PDMR Shareholding
1st Sep 20082:31 pmRNSHolding(s) in Company
26th Aug 20084:56 pmRNSHolding(s) in Company
26th Aug 20087:00 amRNSAcquisition
22nd Aug 200811:08 amRNSHolding(s) in Company
21st Aug 20084:20 pmRNSPublication of Interim Report
19th Aug 20082:11 pmRNSDirector/PDMR Shareholding
18th Aug 20087:00 amRNSInterim Results
31st Jul 20084:14 pmRNSTotal Voting Rights
31st Jul 200812:25 pmRNSResult of Meeting
17th Jul 20084:21 pmRNSBlocklisting Interim Review
15th Jul 20085:08 pmRNSPosting of Circular
15th Jul 20082:23 pmRNSHolding(s) in Company
15th Jul 20087:00 amRNSTrading Update and Corporate
13th Jun 20083:05 pmRNSAdditional Listing
9th May 20087:00 amRNSInterim Management Statement
2nd May 200811:38 amRNSTotal Voting Rights
10th Apr 20083:12 pmRNSAnnual Information Update
8th Apr 20083:23 pmRNSAnnual Report and Accounts
31st Mar 200812:13 pmRNSTotal Voting Rights
17th Mar 20084:36 pmRNSDirector/PDMR Shareholding
11th Mar 20087:01 amRNSPreliminary Results
29th Feb 200811:58 amRNSTotal Voting Rights
6th Feb 20084:11 pmRNSHolding(s) in Company
1st Feb 200811:11 amRNSTotal Voting Rights
17th Jan 20084:42 pmRNSBlocklisting Interim Review
12th Dec 20072:37 pmRNSHolding(s) in Company
10th Dec 200711:57 amRNSDirector/PDMR Shareholding
28th Nov 20073:48 pmRNSDirectorate Change
29th Oct 20072:13 pmRNSHolding(s) in Company
17th Oct 20073:43 pmRNSDirector/PDMR Shareholding
15th Oct 20074:07 pmRNSChange of Registered Address
9th Oct 20074:50 pmRNSDirector/PDMR Shareholding
8th Oct 200712:51 pmRNSDirector/PDMR Shareholding
5th Oct 20073:34 pmRNSDirector/PDMR Shareholding
1st Oct 20072:24 pmRNSDirector Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.